RBS: Sell Almost Everything

For investors hoping that global markets can bounce back from their weak start to 2016, RBS analyst Andrew Roberts has some bad news. In a new report, Roberts says that that things will get much worse from here and urges investors to “sell (almost) everything.”

Bronte Capital Calls For Resignation Of Valeant Board Member

In a new blog post, Bronte Capital analyst John Hempton explores some inconsistencies in Valeant Pharmaceuticals Intl Inc VRX 2.7%’s facts regarding board member Norma Provencio’s involvement in Heartronics/Signalife prior to her tenure at Valeant. After Provencio left Heartronics/Signalife, the company was exposed as a major fraud, and company executive Mitchell Stein went to prison.